dr. hays on potential for parp inhibitor combinations in ovarian cancer
Published 4 years ago • 56 plays • Length 0:51Download video MP4
Download video MP3
Similar videos
-
6:25
combinations with parp inhibitors for ovarian cancer
-
1:40
dr. hardesty on bevacizumab/parp inhibitor combination in ovarian cancer
-
1:11
dr. backes discusses parp inhibitor combinations in ovarian cancer
-
39:03
the therapeutic potential of novel parp inhibitors in the clinic for epithelial ovarian cancer
-
0:56
dr. levine on combos with parp inhibitors in ovarian cancer
-
34:13
expert views on the evolving role of parp inhibitors in the treatment of ovarian cancer
-
1:58
parp inhibitor combinations and future of ovarian cancer
-
1:03:39
precision medicine in ovarian cancer with parp inhibitor therapy and companion diagnostics
-
6:20
parp inhibitors in recurrent ovarian cancer
-
1:29:06
the advanced ovarian cancer treatment palette: candid conversations on parp inhibitors
-
59:14
parp inhibitors in ovarian cancer: clinical updates from sgo 2023
-
9:39
parp inhibitor selection in ovarian cancer
-
3:09
the promising potential of parp inhibitors in ovarian cancer
-
1:22
dr. penson on the eligibility criteria for parp inhibitors in advanced ovarian cancer
-
1:25
dr. emens on the combination of checkpoint inhibitors and parp inhibitors in ovarian cancer
-
2:38
assessing the role of parp inhibitors and immunotherapy in ovarian cancer
-
0:45
dr. coffman on safety concerns with parp inhibitors in ovarian cancer
-
35:35
maximizing the potential of parp inhibitors as first-line maintenance therapy in ovarian cancer
-
3:04
evolving role of parp inhibitors in ovarian cancer